Induction of remission of idiopathic anaphylaxis with rituximab - 02/10/14
Doi : 10.1016/j.jaci.2014.05.032
Arturo Borzutzky, MD a, b 
, Pamela S. Morales, MD a, Verónica Mezzano, MD c, Sofía Nussbaum a, A. Wesley Burks, MD d
, Pamela S. Morales, MD a, Verónica Mezzano, MD c, Sofía Nussbaum a, A. Wesley Burks, MD d a Immunology, Allergy and Rheumatology Unit, Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
b Millennium Institute on Immunology and Immunotherapy, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
c Department of Rheumatology and Clinical Immunology at the School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
d Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC
| Disclosure of potential conflicts of interest: A. Borzutzky has been a speaker for Roche and Novartis Laboratories (Chile); has received research support from Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT grant nos. 1130615 and 1130387) (Chile) and FONIS (grant no. SA13I20173) (Chile); has received lecture fees from Roche Laboratories (Chile) and Pfizer (Chile); and has received travel support from Pfizer (Chile) and Abbott Laboratories (Chile). V. Mezzano has received lecture fees from Brystol-Myers Squibb and has received support for travel, accommodations, and meeting registration from Janssen. A. W. Burks is or has been on the board for Food Allergy Research and Education, the American Academy of Allergy, Asthma & Immunology, and the Food Allergy Initiative; has received consultancy fees from Dynavax Technologies Corp, Genalyte, GLG Research, Perrigo Company, Regeneron Pharmaceuticals, Perosphere Inc, Dow AgroSciences, ExploraMed Development, McNeil Nutritionals, Merck, Nordic Biotech, Norvartis Pharma AG, Nutricia North American, Portola Pharaceuticals, Publicis Healthcare Communications Group, and Unilever; has received research support from Hycor Biomedical; has received lecture fees from Abbott Laboratories, the American College of Allergy, Asthma, and Immunology, and Mylan Speciality; has received royalties from UpToDate; has received payment for development of educational presentations from Levine Children's Hospital and Oak Ridge Associated Universities; and has stock/stock options in Allertein and MastCell Pharmaceuticals. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2014
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 134 - N° 4
P. 981-983 - octobre 2014 Retour au numéro
Article précédent
- Basophils increase in Crohn disease and ulcerative colitis and favor mesenteric lymph node memory TH17/TH1 response
- Laurence Chapuy, Marwa Bsat, Heena Mehta, Manuel Rubio, Keiko Wakahara, Vu Quang Van, Nobuyasu Baba, Cheolho Cheong, Tae Jin Yun, Benoît Panzini, Ramses Wassef, Carole Richard, Raja Tamaz, Geneviève Soucy, Guy Delespesse, Marika Sarfati
- Lessons in gene hunting: A RAG1 mutation presenting with agammaglobulinemia and absence of B cells
- Mona Hedayat, Michel J. Massaad, Yu Nee Lee, Mary Ellen Conley, Jordan S. Orange, Toshiro K. Ohsumi, Waleed Al-Herz, Luigi D. Notarangelo, Raif S. Geha, Janet Chou
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?